As of Jan 13
| -0.45 / -0.83%|
The 1 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 63.00, with a high estimate of 63.00 and a low estimate of 63.00. The median estimate represents a +17.63% increase from the last price of 53.56.
The current consensus among 1 polled investment analysts is to Buy stock in Biospecifics Technologies Corp. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.